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OBJECTIVE—We assessed the relation of diabetes and insulin resistance (IR) on left ventric-
ular (LV) structure and function in African Americans.
RESEARCH DESIGN AND METHODS—Among those receiving echocardiograms in
cycle 1 of the Jackson Heart Study, we assessed the sex-speciﬁc relation of fasting blood glucose
(FBG), diabetes, and IR to LV structure and function, adjusting for age, systolic blood pressure,
antihypertensive medications, and BMI.
RESULTS—Among 2,399 participants, LV mass index (Pwomen =0 . 0 0 0 2a n dPmen = 0.02),
posterior wall thickness (Pwomen =0 . 0 1a n dPmen = 0.05), and interventricular septal wall thick-
ness (Pwomen = 0.01) were related to FBG categories. Among those with normal FBG and no
diabetes, concentric remodeling and low ejection fraction in women and LV mass index and
posterior wall thickness in men were related to IR.
CONCLUSIONS—In the largest study of its kind in a community-based cohort of African
Americans, we found a relation of FBG category and IR to LV structure and function.
Diabetes Care 34:507–509, 2011
A
frican Americans (AAs) have an in-
creased burden of cardiovascular
disease (CVD) and a higher rate
of CVD-related deaths relative to non-
Hispanicwhites,andthecourseoffuture
CVD death rates remains uncertain
partly due to simultaneous increases in
diabetes (1). Diabetes may be linked to
left ventricular hypertrophy (LVH) and
associated adverse cardiovascular out-
comes. In the current study, we investi-
gated the relation of fasting blood glucose
(FBG) category (normal versus im-
pairedversusdiabetes)andinsulinresis-
tance (IR) to LV structure and function
in AA.
RESEARCH DESIGN AND
METHODS—This study was approved
by the Institutional Review Board of
Jackson State University, Tougaloo Col-
lege, and the University of Mississippi
Medical Center. Participants gave written
informed consent.
Study population
The Jackson Heart Study is a longitudinal
community-based cohort study initiated
in 2000 focused on understanding CVD
distribution and determinants in AA (2).
Participantswere18–84yearsoldandliv-
ing in the Jackson, Mississippi tricounty
area (3).
Clinical covariates
Diabetes was deﬁned as a FBG $ 126
mg/dL or a random glucose $ 200 mg/dL,
history of physician diagnosis of diabetes,
or use of insulin or an oral hypoglycemic
agent (4). Impaired FBG was deﬁned in
those who did not have a diagnosis of di-
abetes but who did have a FBG of 110 to
125 mg/dL. IR was calculated using the
formula for homeostasis model assessment
(HOMA-IR) (5).
Echocardiography
Echocardiograms were performed usinga
Sonos 4500 (Hewlett Packard) ultrasound
machine. Final measurements were per-
formed ofﬂine by one cardiologist reader
who has level 3 training in echocardiogra-
phy (T.S.). Cardiac dimensions were mea-
sured according to the American Society
ofEchocardiography(ASE)guidelines.Rel-
ative wall thickness (RWT) was deﬁned as
the ratio of the sum of the posterior wall
thickness (PWT) and interventricular sep-
tal wall thickness (IVST) to the left ventric-
ular internal diastolic dimension (LVIDD).
LVMwascalculatedfromtheASEcorrected
formula (6).
To correct for body size, LVM index
(LVMI) was calculated as LVM (g) divided
by height
2.7 (g/ht
2.7) (7). For function pa-
rameters,fractionalshortening(FS)wascal-
culated as: FS ¼ LVIDD2LVISD=LVIDD.
LV ejection fraction was measured semi-
quantitatively. LV diastolic function param-
eters were measured using spectral Doppler
of mitral inﬂow velocities and pulmonary
vein ﬂow patterns.
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All analyses were sex-speciﬁc. General
linear models were used to assess associ-
ations with continuous LV structure and
function outcome variables, and multiple
logistic regression models were used for
dichotomous outcome variables. We as-
sessedtherelationoftheseoutcomeswith
predictor variables (FBG category [nor-
mal versus impaired versus diabetes] and
IR) and clinical covariates (age, systolic
bloodpressure[BP],mildorgreateraortic
regurgitation, moderate or greater mitral
regurgitation, antihypertensive medication,
heart rate, and BMI). Two models were
developed for continuous and dichoto-
mous outcome variables, where covari-
ates were adjusted for model 1 excluding
BMI, and adjusted for model 2 including
BMI.TheinclusionofBMIinmodel2was
to assess the attenuating effect of BMI.
RESULTS—The analytic study sample
comprised 2,399 participants (63%
women) who were a mean age of 52 6
13 years; of these, 74.2% of women and
73.7% of men were in the normal FBG
category, 11.8% and 16.1% had impaired
FBG,and14.0%and10.1%haddiabetes,
respectively. HOMA-IR scores (median,
interquartile [IQR] range) for women
and men were 3.36 (IQR, 2.30–5.10)
and 2.94 (IQR, 2.11–4.47), respectively.
Across FBG categories, women had
higher BMI and lower diastolic BP than
men (Table 1).
For women, LVMI, IVST, PWT, RWT,
left atrial diameter (LAD), and concentric
remodeling (CR) were all signiﬁcantly
greater (in value or prevalence in the case
of CR) in higher FBG categories. For men,
LVMI, IVST, PWT, LVIDD, LAD, and CR
were all signiﬁcantly greater in the higher
FBG categories. Placing BMI in the ad-
justment attenuated the apparent effect;
however, the association remained sig-
niﬁcant for higher LVMI (P = 0.0002),
IVST (P =0 . 0 1 ) ,P W T( P = 0.01), for lower
prevalence of normal geometry (P =0 . 0 2 )
and higher prevalence of CR (P =0 . 0 5 )i n
women, and for higher LVMI (P =0 . 0 2 ) ,
PWT (P = 0.05), and LAD (P = 0.04) in
men. No evidence of an association was
foundbetweenmeasuresofLVsystolicdys-
functionordiastolicfunctionwithFBGcat-
egories in women or men (P . 0.05).
In women in the normal FBG cate-
gory, IR was marginally related to higher
RWT (P = 0.05) and signiﬁcantly related
toahigherpercentageofparticipantswith
CR (P = 0.02) and lower LV ejection frac-
tion (P = 0.02). In women with impaired
FBG or diabetes, IVST (P = 0.02), PWT
(P = 0.04), and RWT (P = 0.04) were sig-
niﬁcantly greater with higher quartiles of
HOMA-IR score. In men in the normal
FBG category, lower LVMI (P =0 . 0 3 )
andPWT(P=0.01)wererelatedtohigher
HOMA-IR scores. Men with impaired
FBG or diabetes had lower LAD (P =
0.02) with higher HOMA-IR scores.
Although systolic BP was associated
with metabolic status, the relation be-
tween LV structure and metabolic status
was not attenuated by controlling for
systolic BP.
CONCLUSIONS—Our ﬁndings ex-
pand current literature on the effects of
glucose control and IR on the heart to in-
clude a community-based cohort of AA.
Investigators in the Framingham Heart
Study showed that diabetes and glucose
tolerance (GT) were independent con-
tributors to LVM and LVwallthicknessin
non-Hispanic white women (8). Some
studies suggest that GT based on GT test-
ing, which was studied in Framingham,
appears to have a slightly greater risk for
CVD compared with impaired FBG that
was studied in our investigation (9).
Similar to the men in our study,
HypertensionGeneticEpidemiologyNet-
work (HyperGEN) investigators found a
weak relation between IR and LV mea-
sures of structure, suggesting a limited
role of plasma insulin level on LV re-
modeling (10). However, different from
HyperGEN, we also found a signiﬁcant,
Table 1—Sex-speciﬁc metabolic characteristics in women and men by fasting blood glucose category
Variables
Normal fasting glucose Impaired fasting glucose Known diabetes
Women
(n = 1,131)
Men
(n =6 4 4 ) P
Women
(n = 180)
Men
(n =1 4 1 ) P
Women
(n = 214)
Men
(n = 89) P
Age (years) 50 6 12 49 6 13 0.002 59 6 10 56 6 12 0.01 58 6 10 57 6 12 0.33
BMI (kg/m
2) 31.7 6 7.3 28.5 6 5.2 ,0.0001 34.2 6 6.2 30.5 6 5.0 ,0.0001 35.5 6 7.3 32.0 6 5.4 ,0.0001
Waist circumference, in 37.8 6 6.2 38.1 6 5.2 0.34 41.2 6 6.1 41.0 6 4.7 0.50 42.6 6 6.1 42.3 6 5.0 0.64
Systolic blood pressure,
mmHg 123 6 18 124 6 16 0.14 129 6 17 130 6 18 0.66 130 6 17 133 6 18 0.13
Diastolic blood pressure,
mmHg 78 6 10 81 6 10 ,0.0001 78 6 10 82 6 11 0.0002 77 6 98 1 6 10 0.0001
Heart rate, bpm 68 6 96 5 6 9 ,0.0001 68 6 96 8 6 12 0.85 71 6 10 70 6 90 . 3 3
Hypertension, % 48.8 43.3 0.06 76.1 67.4 0.08 87.4 8.0 0.22
Total cholesterol/
high-density lipids 3.7 6 1.0 4.5 6 1.4 ,0.0001 4.0 6 1.1 4.7 6 1.5 ,0.0001 3.8 6 1.1 4.8 6 1.8 ,0.0001
Fasting triglycerides,
mg/dL 90 6 51 106 6 101 0.0002 111 6 63 123 6 82 0.15 126 6 96 139 6 130 0.37
Mitral regurgitation, % 2.4 1.6 0.12 1.11 1.42 0.25 1.87 0.00 0.11
Fasting glucose, mg/dL 87 6 68 8 6 6 ,0.0001 107 6 6 107 6 70 . 7 4 1 4 6 6 60 149 6 54 0.71
Fasting insulin,
IU p50 (25,75p)* 15 (10,18) 13 (9,16) ,0.0001 22 (15,27) 18 (12,22) 0.01 28 (16,32) 38 (13,25) 0.04
HOMA-IR,
IU p50 (25,75p)* 2.8 (2.1,4.0) 2.6 (1.9,3.5) ,0.0001 5.2 (3.9,7.2) 4.3 (3.2,5.8) 0.003 7.4 (4.7,12.4) 6.3 (4.3,9.5) 0.27
Data are shown as mean 6 SD, unless indicated otherwise. P values = comparison by t tests, median test (for insulin and HOMAIR-IR) or x
2 tests. HOMA-IR,
homeostasis model for the assessment insulin resistance. *25,75p = 25th and 75th percentile.
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Diabetes and left ventricular mass in the Jackson Heart Studymore consistent relation between IR and
LVstructureandfunctioninwomeninthe
normal FBG category and also in those
with diabetes, suggesting a potential sex
difference in cardiac response to IR.
LVM and geometry may relate to di-
abetes and IR by their association with
elevated systolic BP(11) caused byarterial
stiffening. By enhancing LV pulsatile
work, increases in end-systolic stress and
myocardial oxygen demands through in-
creased pressure may promote cardiac re-
modeling (12). IR and the accompanying
compensatory hyperinsulinemia may re-
sultintrophiceffectsonmyocardialtissue;
this has been demonstrated in both cell
cultures and animal models (13). In addi-
tion, LVH may result from sodium reten-
tion induced by hyperinsulinemia (12)
associated with obesity in participants
with impaired FBG and diabetes. Finally,
rapid alterations in fatty acid and glucose
metabolites within the cardiomyocyte may
inﬂuence cardiac function (14). Prolonged
exposure to hyperglycemia or hyperlip-
idemia, or both, may lead to lipotoxicity
and the development of contractile dys-
function.
Recentstatisticsontheracialdisparity
of diabetes mortality in the United States
makes clear the need to increase aware-
ness, prevention, and treatment for mi-
norities in particular. Our investigation
supports that obesity, diabetes, and IR
each inﬂuence cardiac structure in AA
menandwomenandcardiacfunctionina
subset of women with IR and normal
FBG. Knowing the potential effects on
cardiac remodeling and mortality, ﬁnd-
ings from this study underscore the need
formoreaggressivemanagementofweight,
diabetes, and hyperinsulinemia in this
group.
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